BAP1 and intrahepatic cholangiocarcinoma: However, the loss of BAP1 was only reported in 50% of cases of intrahepatic cholangiocarcinoma, which still leaves the question of how to classify the other 50% of cases, especially when considering that a small portion of pancreatic carcinomas also shows this loss.